Intersect Ent Inc (XENT) Inventory Turnover Ratio, from first quarter 2022 to first quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Intersect Ent Inc   (NASDAQ: XENT)
 

Intersect Ent Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Intersect Ent Inc 's inventory turnover ratio, the ratio that measures Intersect Ent Inc 's ability to manage its supply chain, sequentially decreased to 1.64 in the first quarter 2022, which does not come as a surprise, as the Intersect Ent Inc continue to experience headwinds, which also impact its supply chain. Intersect Ent Inc 's average inventory processing period in the Mar 31 2022 quarter, has increased to 223 days, from 204 days, in the Dec 31 2021 quarter.

Within Healthcare sector 306 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1806 in the fourth quarter 2021, to 1854.

XENT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Intersect Ent Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XENT Inventory Turnover Ratio (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Inventory Growth 34.2 % 54.3 % 79.75 % 7.51 % -22.47 %
Y / Y Cost of Sales Growth -9.05 % -6.4 % -35.16 % 13.25 % 31.9 %
Inventory Turnover Ratio (TTM) 1.64 1.79 2.02 2.59 2.57
XENT's Total Ranking # 1854 # 1806 # 1746 # 1521 # 1577
Average inventory processing period 223 204 180 141 142
Seq. Inventory Growth -4.63 % -7.27 % 33.19 % 13.94 % 9.65 %
Seq. Cost of Sales Growth -5.51 % 59.98 % -38.95 % -1.45 % -2.75 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 128
Healthcare Sector # 307
Overall Market # 1854

Inventory Turnover Ratio Statistics
High Average Low
3.58 2.14 1.37
(Dec. 30, 2015)   (Dec 31 2019)



XENT Company Profile >> Back to XENT Efficiency Comparisons >> Compare XENT Inventory Turnover Ratio to its Competitors

Financial Statements
Intersect Ent Inc 's Inventories $ 18 Millions Visit XENT's Balance sheet
Intersect Ent Inc 's Cost of Revenues TTM $ 29 Millions Visit XENT's Income Statement
What are XENT's Sales? Visit XENT's Sales by Segment

Other Inventory Turnover Ratios
Intersect Ent Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
XENT's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for XENT's Competitors
Inventory Turnover Ratio for XENT's Suppliers
Inventory Turnover Ratio for XENT's Customers

You may also want to know
XENT's Sales Growth Rates XENT's Pe Price to earnings ratio XENT's Receivables Turnover Ratio XENT's Stock Quote
XENT's Net Income Growth Rates XENT's Ps Price to Sales ratio XENT's Sales per Employee XENT's Asset Turnover Ratio
XENT's Net Margin XENT's Pb Price to Book ratio XENT's Financial Strength Ratios XENT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2022 Inventories at quarter ending Mar 31 2022
Global Cord Blood Corp  4.53 $ 28.916  Millions$ 6  Millions
West Pharmaceutical Services Inc   4.53 $ 1,692.400  Millions$ 373  Millions
T2 Biosystems Inc   4.52 $ 21.118  Millions$ 5  Millions
Novocure Limited  4.52 $ 116.219  Millions$ 26  Millions
Bristol myers Squibb Company  4.50 $ 9,570.000  Millions$ 2,125  Millions
Invacare Holdings Corporation  4.39 $ 645.046  Millions$ 147  Millions
Organogenesis Holdings Inc   4.32 $ 113.824  Millions$ 26  Millions
Escalon Medical Corp   4.28 $ 6.197  Millions$ 1  Millions
Prestige Consumer Healthcare Inc   4.24 $ 466.166  Millions$ 110  Millions
Caredx Inc   4.18 $ 72.396  Millions$ 17  Millions
Integrated Biopharma Inc  4.16 $ 52.609  Millions$ 13  Millions
Orthofix Medical Inc   4.11 $ 117.918  Millions$ 29  Millions
Gilead Sciences Inc   4.07 $ 6,664.000  Millions$ 1,637  Millions
Dynatronics Corporation  4.04 $ 34.991  Millions$ 9  Millions
Akebia Therapeutics Inc   4.02 $ 150.132  Millions$ 37  Millions
Avid Bioservices Inc   4.01 $ 82.949  Millions$ 21  Millions
Biomerica Inc   4.00 $ 12.276  Millions$ 3  Millions
Pfizer Inc  4.00 $ 36,594.000  Millions$ 9,157  Millions
Endo International Plc  3.95 $ 1,188.986  Millions$ 301  Millions
Epizyme Inc.  3.95 $ 10.282  Millions$ 3  Millions
Antares Pharma Inc   3.95 $ 57.568  Millions$ 15  Millions
Precision Optics Corporation Inc   3.92 $ 9.285  Millions$ 2  Millions
Inotiv Inc   3.92 $ 92.484  Millions$ 24  Millions
Ocular Therapeutix Inc   3.90 $ 4.814  Millions$ 1  Millions
Zai Lab Limited  3.84 $ 60.377  Millions$ 16  Millions
Horizon Therapeutics Public Limited Company  3.83 $ 909.206  Millions$ 237  Millions
Cadre Holdings inc   3.83 $ 254.238  Millions$ 66  Millions
Vericel Corporation  3.81 $ 51.198  Millions$ 13  Millions
3m Company  3.81 $ 19,096.000  Millions$ 5,017  Millions
Nabriva Therapeutics Plc  3.80 $ 16.447  Millions$ 4  Millions

Date modified: 2026-08-29T17:23:21+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.